Labetalol Hydrochloride

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70377-062
  • Package NDC 70377-062-11
  • Package NDC 70377-062-12
  • Package NDC 70377-062-13
  • Application number ANDA209603
  • SPL ID f285cda1-e518-405e-9362-292ae2e14954
  • SPL set ID 27e4ab03-c17b-4268-912c-e45a5e8f8dd8
  • UNII 1GEV3BAW9J
  • RxCUI 896758
  • RxCUI 896762
  • RxCUI 896766
  • RxCUI 896983

What the source publishes

Labeler
Biocon Pharma Inc.
Active ingredients
Labetalol Hydrochloride
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70377-062_f285cda1-e518-405e-9362-292ae2e14954
{
  "name": "Labetalol Hydrochloride",
  "splId": "f285cda1-e518-405e-9362-292ae2e14954",
  "labels": [
    {
      "setId": "27e4ab03-c17b-4268-912c-e45a5e8f8dd8",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27e4ab03-c17b-4268-912c-e45a5e8f8dd8",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=27e4ab03-c17b-4268-912c-e45a5e8f8dd8"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Biocon Pharma Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED in 1 BOTTLE (70377-062-11)",
      "package_ndc": "70377-062-11",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210527"
    },
    {
      "sample": false,
      "description": "100 TABLET, FILM COATED in 1 BOTTLE (70377-062-12)",
      "package_ndc": "70377-062-12",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210527"
    },
    {
      "sample": false,
      "description": "500 TABLET, FILM COATED in 1 BOTTLE (70377-062-13)",
      "package_ndc": "70377-062-13",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210527"
    }
  ],
  "productId": "70377-062_f285cda1-e518-405e-9362-292ae2e14954",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "70377-062",
  "deaSchedule": null,
  "genericName": "Labetalol Hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LABETALOL HYDROCHLORIDE",
      "strength": "300 mg/1"
    }
  ],
  "applicationNumber": "ANDA209603",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210527",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0370377061134",
      "0370377060120",
      "0370377063121",
      "0370377063114"
    ],
    "unii": [
      "1GEV3BAW9J"
    ],
    "rxcui": [
      "896758",
      "896762",
      "896766",
      "896983"
    ],
    "spl_set_id": [
      "27e4ab03-c17b-4268-912c-e45a5e8f8dd8"
    ],
    "manufacturer_name": [
      "Biocon Pharma Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70377-062_f285cda1-e518-405e-9362-292ae2e14954"